ID: ALA4396413
Type: Functional
Description: Antiinflammatory activity in human HepG2 cells assessed as inhibition of TNFalpha-induced IkappaBalpha degradation at 2 uM pretreated for 1 hr followed by TNFalpha addition and measured after 30 mins by Western blot analysis
Organism: Homo sapiens
Cell type: HepG2
Bioactivity
Activity Types for Assay ALA4396413
Inhibition
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
464.65 | 6.79 | 6.79 |
494.72 | 7.34 | 7.34 |
450.62 | 6.70 | 6.70 |
452.64 | 6.64 | 6.64 |
478.67 | 7.18 | 7.18 |
463.66 | 6.36 | 6.36 |
492.70 | 7.56 | 7.56 |
477.69 | 6.75 | 6.75 |
491.72 | 7.14 | 7.14 |
466.62 | 6.28 | 6.28 |
517.71 | 7.56 | 7.56 |
480.69 | 7.04 | 7.04 |
528.68 | 7.51 | 7.51 |
466.66 | 7.20 | 7.20 |
492.70 | 7.26 | 7.26 |
452.61 | 7.11 | 7.11 |
560.67 | 7.63 | 7.63 |
466.66 | 6.95 | 6.95 |
511.66 | 6.46 | 6.46 |
478.67 | 6.87 | 6.87 |
508.70 | 7.16 | 7.16 |
481.68 | 6.14 | 6.14 |
466.66 | 6.95 | 6.95 |
480.69 | 7.25 | 7.25 |
480.69 | 7.04 | 7.04 |